About Lifecare
Lifecare is a company based in Bergen (Norway) founded in 2006. It operates as a HealthTech. The company has 33 employees. Lifecare has completed 1 acquisition, including RemovAid. Lifecare offers products and services including Sencell, Veterinary Solutions, and RemovAid. Lifecare operates in a competitive market with competitors including GlySens, EyeSense, Metronom Health, GluSense and Applied Biosensors, among others.
- Headquarter Bergen, Norway
- Employees 33
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lifecare.no
- Social LinkedIn
- Legal Name Lifecare Asa
- Annual Revenue$11.11 K (USD)-95.48as on Dec 31, 2025
- Net Profit-$11.86 M (USD)-66.55as on Dec 31, 2025
- EBITDA-$12.74 M (USD)-59.85as on Dec 31, 2025
- InvestorsEuropean Union
& 1 more
- Employee Count33
- Investments & Acquisitions
Products & Services of Lifecare
Lifecare offers a comprehensive portfolio of products and services, including Sencell, Veterinary Solutions, and RemovAid.
Miniaturized glucose sensor for continuous diabetes monitoring.
Glucose monitoring solutions developed for pets' health.
Innovative device aiding in medical sensor removal.
Funding Insights of Lifecare
- Total Rounds 4
- First Round $52,585
(Aug 2016)
- Investors Count 2
All 4 funding rounds of Lifecare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | – | Post-IPO | – | – | – |
| Oct 2020 | $668,843 | Grant | – | – | |
| Dec 2016 | $52,678 | Grant | – | – | |
| Aug 2016 | $52,585 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Lifecare
Lifecare has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Lifecare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lifecare
7 people are tracked at Lifecare (4 in leadership, 3 in team); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
Rune Frisvold | Managing Director | Leadership |
Ahmad Fazli | Vice President Manufacturing | Leadership |
Joacim Holter | CEO | Leadership |
Prof. Dr. Dr. med. Andreas Pfützner | Chief Scientific Officer | Leadership |
Lea Weingärtner | Research Assistant + QMS Manager | Team |
Jordan Gardiner | Senior Research Chemist | Team |
Dr Jeanette Hütges | Research And Development Scientist | Team |
Complete people profiles for Lifecare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Lifecare
Lifecare is a publicly listed company on the OSL with ticker symbol LIFE in Norway, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 May 2021
- Listed onFRA: LFC
- Listed entityLifecare ASA
- Exchange sectorHealth technology
- ISINNO0013355859
- Share price0.41 NOK (-0.12% on the day) · 2026-10-09
- Market capitalisation174,937,369.00 NOK
- EPS (diluted, trailing year)-1.81 NOK
- Volume (last session)5,261,596
Financials of Lifecare
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 112,000 NOK | -119.5M NOK | -128.4M NOK |
| 2024 | 2.5M NOK | -71.8M NOK | -80.4M NOK |
| 2023 | 13.1M NOK | -35.3M NOK | -32.1M NOK |
| 2022 | 22.1M NOK | -17.2M NOK | -14.6M NOK |
| 2021 | 324,410 NOK | -15.9M NOK | -16.6M NOK |
Detailed financial statements for Lifecare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lifecare
Lifecare has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RemovAid.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical devices for subdermal implant removal are developed. | removaid.com | Oslo, Norway | 2012 | Apr 2024 | •••• |
Complete acquisition details for Lifecare
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Lifecare
5 dated milestones of Lifecare across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Lifecare is founded.
- Funding First funding round of $53K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires RemovAid.
Competitors of Lifecare
Lifecare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlySens, EyeSense, Metronom Health, GluSense and Applied Biosensors, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glysens.com | 1997 | San Diego, United States | $47M | 29 | Implantable Continuous glucose monitoring device | |
| eyesense.com | 2006 | Stockstadt Am Main, Germany | $8.23M | 15 | Continuous glucose monitoring systems for diabetes management are developed. | |
| metronomhealth.com | 2009 | Laguna Hills, United States | $49.14M | 69 | Continuous glucose monitoring systems for diabetes management are developed. | |
| glusensemedical.com | 2007 | Lod, Israel | $26.9M | – | Develops implantable sensors for monitoring glucose levels in type 1 diabetes patients. | |
| appliedbiosensors.com | 2013 | Salt Lake, United States | $674,999 | – | Wireless telemetry systems are developed for continuous multi-analyte monitoring. | |
| securecell.ch | 2009 | Zurich, Switzerland | – | – | Bioprocessing solutions for monitoring and evaluation are developed. | |
| invivomon.com | 2009 | Pittsburgh, United States | – | – | Offers blood glucose monitoring devices for health management. |
Detailed competitors of Lifecare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lifecare
The website of Lifecare (lifecare.no) receives about 6K visits a month.
- Monthly visits6K
▲ 14.8% vs previous month
Latest news on Lifecare
Complete news archive for Lifecare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Lifecare
10 companies that operate in the same segment as Lifecare (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lifecare
Lifecare was founded in 2006 and raised its 1st funding round 10 years after it was founded.
Lifecare is headquartered in Bergen, Norway. It is registered at Bergen, Vestland, Norway.
Lifecare has 33 employees.
Annual revenue of Lifecare is $11.11K as on Dec 31, 2025.
Lifecare is engaged in the development of miniaturized and implantable nanobiosensors for continuous monitoring of glucose and other biomarkers. The company primarily targets the healthcare sector, with a strong emphasis on diabetes management, aiming to support over 500 million individuals worldwide. Solutions like Sencell, a rice-grain-sized glucose sensor, are designed to improve the quality of life for diabetes patients and pets by offering long-term monitoring capabilities. Research and development activities are conducted across multiple European locations, ensuring innovation in medical nanotechnology.
Lifecare's top competitors include Metronom Health, GlySens and EyeSense.
Lifecare offers Sencell, Veterinary Solutions, and RemovAid.
Yes, Lifecare is publicly traded on OSL under the ticker symbol LIFE.
Lifecare has made 1 acquisition, including RemovAid.
Lifecare has 2 investors. Key investors include European Union, and EIC Fund.
Lifecare operates through Lifecare Asa.